Log in to search using one of your social media accounts:

 

More Cases of Breast Implant-Linked Cancer: FDA
The disease -- breast implant-associated anaplastic large-cell lymphoma -- is not breast cancer. It's an immune system cancer that can usually be cured by surgery alone if detected early, The Times reported. (Source: WebMD Health)
Source: WebMD Health - March 23, 2018 Category: Consumer Health News Source Type: news

Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Recommended for Approval for the Same Indications as Herceptin® (Trastuzumab) Positive Opinion for ABP 980 is Supported by Phase 3 Data in Patients With HER2-Postive Early Breast Cancer THOUSAND OAKS, Calif., March 23, 2018 -- (Healthcare Sales &... Biopharmaceuticals, Oncology, Regulatory Amgen, Allergan, biosimilar, Herceptin, trastuzumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 23, 2018 Category: Pharmaceuticals Source Type: news

Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Data featured in Nature Communications showed ADAPT Biotargeting System significantly out-performed industry standard HER2 testing IRVING, Texas, March 23, 2018 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences®, a leading innovator ... Biopharmaceuticals, Diagnostics, Oncology Caris Life Sciences, ADAPT Biotargeting System, trastuzumab, Herceptin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 23, 2018 Category: Pharmaceuticals Source Type: news

How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test
23AndMe's newest product tests for three variants of the BRCA gene that have been linked to breast and ovarian cancer, but the company had to take steps to guard against confusion and anxiety among customers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 23, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin ®) For The Treatment Of Three Types Of Cancer
Recommended for Approval for the Same Indications as Herceptin® (Trastuzumab) Positive Opinion for ABP 980 is Supported by Phase 3 Data in Patients With HER2-Postive Early Breast Cancer THOUSAND OAKS, Calif., March 23, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the marketing authorization of ABP 980, a biosimilar to Herceptin® (trastuzumab). ABP 980 has been recommended for approval for the treatment of the same three types of...
Source: Amgen News Release - March 23, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Medical students get little training in radiation oncology
Medical school students receive little formal instruction in radiation oncology,...Read more on AuntMinnie.comRelated Reading: ASRT backs ASTRO safety, quality initiative ASTRO releases new breast radiation therapy guideline Siris signs on UCSF for radiation oncology software ASTRO commends payment freeze for radiation treatment Microbubbles improve breast cancer radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2018 Category: Radiology Source Type: news

Lower radiotherapy dose is good as targeted breast cancer treatment
Thousands of women who have radiotherapy for breast cancer could be spared severe side-effects after scientists found that targeted treatments or lower doses were just as effective. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2018 Category: Consumer Health News Source Type: news

Oncofertility Counseling in Breast Cancer Patients With BRCA Oncofertility Counseling in Breast Cancer Patients With BRCA
How should women carrying BRCA 1/2 be counseled about their fertility management?Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Diagnosing breast cancer using red light
(The Optical Society) At the OSA Biophotonics Congress: Biomedical Optics meeting, held 3-6 April in Hollywood, Florida, USA, researchers from Milan, Italy, will report an advance in instrument development that increases the sensitivity of OM by as much as 1000-fold. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2018 Category: International Medicine & Public Health Source Type: news

Breast cancer: Women suffering from early stage 'could avoid unnecessary mastectomies'
MANY women who suffer from early stage breast cancer could avoid unnecessary mastectomies because they have a very low risk of the disease developing again within five years of surgery, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - March 23, 2018 Category: Consumer Health News Source Type: news

Breast Cancer Chemo Responders May Avoid Lymph Node Surgery Breast Cancer Chemo Responders May Avoid Lymph Node Surgery
Women with aggressive forms of breast cancer may be able to avoid lymph node surgery and its adverse effects if they respond well to chemotherapy, the results of two studies suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer symptoms: Four changes in the nipple that indicate the disease
BREAST cancer symptoms do not just involve a lump in the breast. Many of the signs include a lump or swelling in the armpits. While this type of cancer is usually associated with women, in rare cases it can develop in men. There are four changes in the nipple you should always watch out for. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2018 Category: Consumer Health News Source Type: news

Fracking pollutes the water; chemicals contribute to breast cancer by causing uncontrolled cell division
(Natural News) Laboratory mice are subject to many of the vulnerabilities that affect humans. So, when a recently-released study warns that female lab mice developed pre-cancerous growths in their mammary glands after they were exposed to high levels of chemicals used for fracking, it stands to reason there’s something toxic about those chemicals. The study... (Source: NaturalNews.com)
Source: NaturalNews.com - March 22, 2018 Category: Consumer Health News Source Type: news

Breast cancer symptoms: Four changes in the nipple men should watch out for
BREAST cancer symptoms do not just involve a lump in the breast. Many of the signs include changes in the nipple and even a lump or swelling in the armpits. While this type of cancer is usually associated with women, in rare cases it can develop in men. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2018 Category: Consumer Health News Source Type: news

New ASTRO Guidelines Recommend Hypofractionated Breast Irradiation
ASTRO has released new guidelines recommending hypofractionated whole-breast irradiation for women with breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 22, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news

Breast cancer symptoms in men: Four changes in the nipple to watch for
BREAST cancer symptoms do not just involve a lump in the breast. Many of the signs include changes in the nipple and even a lump or swelling in the armpits. While this type of cancer is usually associated with women, in rare cases it can develop in men. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2018 Category: Consumer Health News Source Type: news

HER2 Is Not a Cancer Subtype but Rather a Pan-Cancer Event HER2 Is Not a Cancer Subtype but Rather a Pan-Cancer Event
Research in breast cancer genomics reveals the potential for combining anti-HER2 therapy with anti-androgen agents.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Fewer breast cancer patients need radical surgery if they are pre-treated with targeted drugs
(ECCO-the European CanCer Organisation) Extensive surgery involving mastectomy and removal of several lymph nodes can be safely avoided for more women with some types of breast cancer, if they receive targeted drugs before surgery, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Low risk of a local recurrence 5 years after surgery for early breast cancer patients
(ECCO-the European CanCer Organisation) Women with small, low grade, well-defined breast tumours and a genetic profile that shows they are at low risk of the cancer metastasising have only a 1.4% risk of the cancer returning to the site of the original tumour or the nearby lymph nodes within five years, according to new results from a large randomised trial of nearly 7000 patients presented at the European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Women report fewer adverse side effects from partial or reduced breast radiotherapy
(ECCO-the European CanCer Organisation) The average number of moderate or marked side-effects reported by breast cancer patients is lower if they are treated with radiotherapy to part of the breast or a reduced dose to the whole breast, rather than with standard radiotherapy to the whole breast, according to new findings presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Researchers identify compound to prevent breast cancer cells from activating in brain
(Houston Methodist) Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Men should be included in trials to find better treatments for breast cancer
(ECCO-the European CanCer Organisation) Professor Robert Mansel, Chair of the 11th European Breast Cancer Conference (EBCC-11) and Emeritus Professor of Surgery at Cardiff University School of Medicine, UK, has called for men to be included in trials to improve treatments for breast cancer. This follows new research presented at EBCC-11 on Friday that show that if women are pre-treated with targeted drugs to shrink tumours before surgery, they could avoid radical surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Indian rural women late in seeking breast cancer care
(Umea University) Women in rural India are waiting long before seeking medical care for breast cancer. Most of the Indian women do not know the possibility of inspecting their own body and many of them have not even heard of breast cancer. This is shown in a new dissertation at Ume å University, Sweden. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2018 Category: International Medicine & Public Health Source Type: news

Three-in-one molecule shows promise in helping certain breast cancer patients
(Medical College of Georgia at Augusta University) A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for, scientists report.This chimera, created by a team at the Georgia Cancer Center, has the ability to simultaneously decrease the expression of three growth factors that are over-expressed in some cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

As Mammograms Became Widespread, Breast Tumor Size Shrank
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Breast Symptoms at Mammogram May Raise Future Cancer Risk
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

More Cases Are Reported of Unusual Cancer Linked to Breast Implants
Women with breast implants have an increased risk of a type of lymphoma that can usually be cured by surgery alone — but not always. (Source: NYT Health)
Source: NYT Health - March 21, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Implants Breasts Allergan Inc Breast Cancer Non-Hodgkin's Lymphoma Mentor Worldwide LLC Food and Drug Administration American Society for Aesthetic Plastic Surgery Source Type: news

Protecting Breast Cancer Patients From Cardiac Adverse Effects of Treatment With Anthracyclines and HER2-Targeted Therapies
During the 2018 Miami Breast Cancer Conference, cardiologist Dr. Jean-Bernard Durand discussed protecting patients who are being treated with anthracyclines and HER2-targeted therapies from serious cardiac adverse events. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2018 Category: Cancer & Oncology Authors: Jean-Bernard Durand, MD Tags: Conference Report Conferences/MBCC Source Type: news

Breast Symptoms at Mammogram May Raise Future Cancer Risk
WEDNESDAY, March 21, 2018 -- Women with breast symptoms at a regular cancer screening are more likely to develop breast cancer before their next screening, a new study finds. The study included women who took part in the Finnish National Breast... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 21, 2018 Category: General Medicine Source Type: news

Parasite Drug Shows Effectiveness Against Mesothelioma
Dr. Antonio Giordano believes his team has cleared the path to the next breakthrough in the treatment of malignant pleural mesothelioma. The advancement involves a new use for an old drug, pyrvinium pamoate, which doctors have successfully used for more than 50 years to treat infections of pinworm parasite. “This drug that no one expected to be involved with mesothelioma is potentially a new weapon against this aggressive type of tumor,” Giordano told Asbestos.com. “Our findings are exciting, very exciting. This one can move forward.” Giordano is the founder and director of the Sbarro Health Researc...
Source: Asbestos and Mesothelioma News - March 21, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Average size of breast tumors decreased following introduction of screening but is now increasing
(ECCO-the European CanCer Organisation) The average size of breast cancers at diagnosis decreased dramatically in the 1980s and 1990s following the introduction of screening, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2018 Category: Cancer & Oncology Source Type: news

Model created to help life insurers calculate breast cancer survivors' risk of death
(ECCO-the European CanCer Organisation) As early detection and treatment of breast cancer improves, more and more women are surviving the disease. However, they still face challenges, which include determining the moment when it might be reasonable to state they are 'cured' of the disease, and obtaining life insurance. At the European Breast Cancer Conference Dutch researchers describe how they have created a model to help life insurers calculate breast cancer survivors' risk of death more accurately (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Department of Defense grant to test promising treatment for triple-negative breast cancer
(University of Illinois at Chicago) A unique cell surface protein found on triple-negative type breast cancer cells called JAG1 is a promising new therapeutic target for this hard-to-treat and highly metastatic type of breast cancer, according to researchers at the University of Illinois at Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 21, 2018 Category: Cancer & Oncology Source Type: news

Lymph node surgery could be avoided for some women with aggressive types of breast cancer
(ECCO-the European CanCer Organisation) Sentinel lymph node biopsies, where lymph nodes are surgically removed to check for signs of breast cancer spread, could be safely avoided for some women, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2018 Category: International Medicine & Public Health Source Type: news

Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Patrick I. Borgen, MD Tags: Breast Cancer Conference Report Conferences/MBCC Source Type: news

Why Some Breast Cancer Becomes Resistant to Hormone Therapy Why Some Breast Cancer Becomes Resistant to Hormone Therapy
Acquired mutations in HER2 explain some of the resistance to hormone therapy seen in metastatic breast cancer; this unexpected finding offers a way to clinically manage these patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breast cancer warning - five signs of deadly disease that could also affect men
BREAST cancer symptoms affect almost 60,000 people in the UK every year, including men, according to Cancer Research UK. These are the warning signs of a tumour, which indicate you should see your doctor - and breast pain isn ’t one of them. (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2018 Category: Consumer Health News Source Type: news

Screening Mammography for Average-Risk Women Screening Mammography for Average-Risk Women
Learn about initiation, frequency, and duration of screening mammography for women at average risk of breast cancer.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Double mastectomy to prevent cancer reduces risk of dying in BRCA1 mutation carriers
(ECCO-the European CanCer Organisation) Healthy women who carry a breast cancer-causing mutation in the BRCA1 gene, not only reduce their risk of developing the disease but also their chances of dying from it if they have both breasts removed, according to new research presented at the 11th European Breast Cancer Conference. However, the study also found that for women with a mutation in the BRCA2 gene, there was no difference in their chances of dying from the disease whether they opted for double mastectomy or closer surveillance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
(ECCO-the European CanCer Organisation) The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+
(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Cannabis oil: Meet the woman taking it for breast cancer recovery
Nikki Bednall says she takes cannabis oil through "desperation not recreation" after her breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 20, 2018 Category: Consumer Health News Source Type: news

Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer
Carboplatin should be considered as a potential component of neoadjuvant chemotherapy for women with high-risk, triple-negative breast cancer, regardless of BRCA status, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

How California can break down barriers to breast cancer treatment
More than 29,000 women in California will be diagnosed with breast cancer in 2018. Many of them — especially low-income women, who suffer the worst survival rates — will face economic, emotional and structural obstacles to getting treatment and follow-up care.“Breast cancer is one of the most common diseases, so why is it still so hard for women to get adequate care?” asked Ninez Ponce, associate director of theUCLA Center for Health Policy Research and co-author of atwo-year study of breast cancer barriers in California.  “Women who face the hardship of illness should not also have ...
Source: UCLA Newsroom: Health Sciences - March 19, 2018 Category: Universities & Medical Training Source Type: news

Opinion: No, FDA Didnt Really Approve 23andMes BRCA Test
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers. (Source: The Scientist)
Source: The Scientist - March 19, 2018 Category: Science Tags: News & Opinion,Opinion Source Type: news

Medical News Today: Breast cancer: Obesity may hinder some treatments
Obesity, which is linked to lower survival in many cancers, may be why drugs that inhibit growth of blood vessels that feed cancer don't work, says study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 19, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Going beyond social support: fear of receiving compassion from others predicts depression symptoms in breast cancer patients - Trindade IA, Ferreira C, Borrego M, Ponte A, Carvalho C, Pinto-Gouveia J.
BACKGROUND: Recent studies have highlighted the importance of being able to receive compassion and affiliative signals from others. The main aim of the present study was to explore whether social support and fear of receiving compassion from others are pre... (Source: SafetyLit)
Source: SafetyLit - March 19, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

The use of immunotherapy to treat metastatic breast cancer
(Bentham Science Publishers) The Authors review immunotherapy attempts to treat metastatic breast cancer. They include a) the addition of cytokines to endocrine therapy, b) monoclonal antibodies associated to chemotherapy and c) vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

Why are women at high breast cancer risk not having supplemental MRI screening?
(Mary Ann Liebert, Inc./Genetic Engineering News) Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly underutilized even though access is widely available. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news